• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初诊帕金森病帕金森进展标志物倡议参与者中非运动症状的药物治疗使用。

Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson's Disease Parkinson's Progression Markers Initiative Participants.

机构信息

Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.

Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

J Parkinsons Dis. 2020;10(3):1239-1243. doi: 10.3233/JPD-201973.

DOI:10.3233/JPD-201973
PMID:32417797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7415719/
Abstract

Parkinson's disease (PD) patients experience a range of non-motor symptoms that are believed to be related to disease pathophysiology, many of which are treatable by medications. Among newly-diagnosed PD participants in the Parkinson's Progression Markers Initiative study, we describe (1) the frequency of medication use for common non-motor symptoms, and (2) when non-motor symptomatic treatment was initiated relative to PD diagnosis. Non-motor medication use was reported by 73% of participants, most commonly for depression, constipation, and anxiety. Treatment of some non-motor symptoms, notably depression, antedated diagnosis. These data may be useful for studies of non-motor symptoms in PD.

摘要

帕金森病(PD)患者经历一系列被认为与疾病病理生理学相关的非运动症状,其中许多症状可以通过药物治疗。在帕金森进展标志物倡议研究中,我们描述了(1)新发 PD 患者使用药物治疗常见非运动症状的频率,以及(2)非运动症状治疗相对于 PD 诊断的起始时间。73%的参与者报告了非运动药物的使用,最常见的是用于治疗抑郁、便秘和焦虑。一些非运动症状的治疗,特别是抑郁,早于诊断。这些数据可能对 PD 中非运动症状的研究有用。

相似文献

1
Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson's Disease Parkinson's Progression Markers Initiative Participants.初诊帕金森病帕金森进展标志物倡议参与者中非运动症状的药物治疗使用。
J Parkinsons Dis. 2020;10(3):1239-1243. doi: 10.3233/JPD-201973.
2
Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson's Disease: A Retrospective Study.帕金森病患者自我感知的运动前症状负荷:一项回顾性研究。
J Parkinsons Dis. 2016;6(1):183-90. doi: 10.3233/JPD-150705.
3
Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.运动前症状与帕金森病风险:墨西哥人群的病例对照研究
Clin Neurol Neurosurg. 2017 Sep;160:46-49. doi: 10.1016/j.clineuro.2017.06.010. Epub 2017 Jun 15.
4
[Mirapex (pramipexole) in the treatment of non-motor disturbances in Parkinson's disease].[森福罗(普拉克索)治疗帕金森病的非运动障碍]
Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(5):32-8.
5
[Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind].
Tijdschr Psychiatr. 2020;62(1):62-72.
6
Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.便秘与早期未经药物治疗的帕金森病患者的多巴胺转运体病理无关。
Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.
7
Non-recognition of depression and other non-motor symptoms in Parkinson's disease.帕金森病中抑郁症及其他非运动症状的未被识别情况。
Parkinsonism Relat Disord. 2002 Jan;8(3):193-7. doi: 10.1016/s1353-8020(01)00015-3.
8
Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease.治疗和未治疗的中国早期帕金森病患者的非运动症状。
Tohoku J Exp Med. 2014 Feb;232(2):129-36. doi: 10.1620/tjem.232.129.
9
Sleep quality is associated with the severity of clinical symptoms in Parkinson's disease.睡眠质量与帕金森病临床症状的严重程度相关。
Acta Neurol Belg. 2018 Mar;118(1):85-91. doi: 10.1007/s13760-017-0868-6. Epub 2017 Dec 5.
10
Impact of sleep quality on the quality of life of patients with Parkinson's disease: a questionnaire based study.睡眠质量对帕金森病患者生活质量的影响:一项基于问卷调查的研究。
Clin Neurol Neurosurg. 2016 Sep;148:29-34. doi: 10.1016/j.clineuro.2016.06.014. Epub 2016 Jun 23.

引用本文的文献

1
Grey matter volume differences across Parkinson's disease motor subtypes in the supplementary motor cortex.帕金森病运动亚型在辅助运动区的灰质体积差异
Neuroimage Clin. 2025;45:103724. doi: 10.1016/j.nicl.2024.103724. Epub 2024 Dec 10.
2
Reply to: Correlation of Antidepressant Use and Symptom Time Period in Dream Enactment Behaviors.回复:梦呓行为中抗抑郁药物使用与症状时间段的相关性
Mov Disord Clin Pract. 2021 Dec 3;9(1):132-133. doi: 10.1002/mdc3.13377. eCollection 2022 Jan.

本文引用的文献

1
Symptom burden among individuals with Parkinson disease: A national survey.帕金森病患者的症状负担:一项全国性调查。
Neurol Clin Pract. 2020 Feb;10(1):65-72. doi: 10.1212/CPJ.0000000000000746. Epub 2019 Nov 18.
2
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.帕金森病非运动症状治疗的研究进展——基于循证医学的评价
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
3
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.早期帕金森病患者的健康相关生活质量:非运动症状的影响。
Mov Disord. 2014 Feb;29(2):195-202. doi: 10.1002/mds.25664. Epub 2013 Oct 7.
4
The Parkinson Progression Marker Initiative (PPMI).帕金森进展标志物倡议(PPMI)。
Prog Neurobiol. 2011 Dec;95(4):629-35. doi: 10.1016/j.pneurobio.2011.09.005. Epub 2011 Sep 14.
5
The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.帕金森病患者非运动症状对健康相关生活质量的影响。
Mov Disord. 2011 Feb 15;26(3):399-406. doi: 10.1002/mds.23462. Epub 2011 Jan 24.
6
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.PRIAMO 研究:多中心评估帕金森病的非运动症状及其对生活质量的影响。
Mov Disord. 2009 Aug 15;24(11):1641-9. doi: 10.1002/mds.22643.
7
An effort to improve electronic health record medication list accuracy between visits: patients' and physicians' response.提高就诊期间电子健康记录用药清单准确性的努力:患者和医生的反应。
Int J Med Inform. 2008 Mar;77(3):153-60. doi: 10.1016/j.ijmedinf.2007.03.001. Epub 2007 Apr 16.
8
Assessing the accuracy of computerized medication histories.评估计算机化用药史的准确性。
Am J Manag Care. 2004 Nov;10(11 Pt 2):872-7.
9
The accuracy of medication data in an outpatient electronic medical record.门诊电子病历中用药数据的准确性。
J Am Med Inform Assoc. 1996 May-Jun;3(3):234-44. doi: 10.1136/jamia.1996.96310637.